A Phase I/IIa trial to evaluate oral testosterone product TSX-011 in japanese patients.

Trial Profile

A Phase I/IIa trial to evaluate oral testosterone product TSX-011 in japanese patients.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 03 May 2017

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 May 2017 New trial record
    • 27 Apr 2017 According to a TesoRx media release, the company anticipate that this study will be conducted in the US later this year, and will include Japanese patients to expedite development in both regions.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top